0.5302
Precedente Chiudi:
$0.534
Aprire:
$0.5192
Volume 24 ore:
9.05M
Relative Volume:
1.63
Capitalizzazione di mercato:
$159.97M
Reddito:
$52.29M
Utile/perdita netta:
$-134.84M
Rapporto P/E:
-0.7069
EPS:
-0.75
Flusso di cassa netto:
$-117.11M
1 W Prestazione:
-2.05%
1M Prestazione:
-0.90%
6M Prestazione:
-38.33%
1 anno Prestazione:
-33.58%
Sangamo Therapeutics Inc Stock (SGMO) Company Profile
Nome
Sangamo Therapeutics Inc
Settore
Industria
Telefono
(510) 970-6000
Indirizzo
501 CANAL BLVD., RICHMOND, CA
Confronta SGMO con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
SGMO
Sangamo Therapeutics Inc
|
0.5302 | 162.74M | 52.29M | -134.84M | -117.11M | -0.75 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Sangamo Therapeutics Inc Stock (SGMO) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-13 | Aggiornamento | Truist | Hold → Buy |
2024-12-10 | Reiterato | H.C. Wainwright | Buy |
2023-11-03 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2023-04-28 | Downgrade | BofA Securities | Neutral → Underperform |
2023-02-27 | Aggiornamento | Wedbush | Neutral → Outperform |
2023-01-06 | Downgrade | BofA Securities | Buy → Neutral |
2022-06-13 | Ripresa | Wedbush | Neutral |
2021-05-04 | Iniziato | RBC Capital Mkts | Outperform |
2021-01-07 | Ripresa | Guggenheim | Neutral |
2021-01-06 | Iniziato | Stifel | Hold |
2020-12-16 | Ripresa | H.C. Wainwright | Buy |
2020-09-08 | Iniziato | BofA Securities | Buy |
2020-07-07 | Iniziato | SunTrust | Buy |
2019-08-26 | Iniziato | H.C. Wainwright | Buy |
2018-11-14 | Downgrade | JP Morgan | Overweight → Neutral |
2018-11-09 | Downgrade | Guggenheim | Buy → Neutral |
2018-10-10 | Iniziato | Guggenheim | Buy |
2018-06-20 | Iniziato | BofA/Merrill | Buy |
2017-11-15 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
2017-06-22 | Ripresa | Jefferies | Buy |
2016-11-01 | Downgrade | Wedbush | Outperform → Neutral |
2016-10-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
2015-12-04 | Iniziato | Wells Fargo | Outperform |
2015-10-23 | Ripresa | Jefferies | Buy |
2013-05-03 | Iniziato | BioLogic Equity Research | Sell |
2011-02-23 | Reiterato | JMP Securities | Mkt Outperform |
2010-07-29 | Reiterato | Wedbush | Outperform |
2009-10-19 | Iniziato | Brean Murray | Sell |
2009-10-07 | Reiterato | Leerink Swann | Outperform |
2009-08-25 | Reiterato | JMP Securities | Mkt Outperform |
Mostra tutto
Sangamo Therapeutics Inc Borsa (SGMO) Ultime notizie
Analyzing Sangamo Therapeutics Inc. with risk reward ratio charts2025 EndofYear Setup & Verified Chart Pattern Signals - Newser
Real time breakdown of Sangamo Therapeutics Inc. stock performance2025 Short Interest & Advanced Swing Trade Entry Plans - Newser
Should I buy Sangamo Therapeutics Inc. stock now2025 Biggest Moves & Daily Growth Stock Investment Tips - khodrobank.com
Sangamo Therapeutics Inc.’s volatility index tracking explainedTrade Volume Report & Short-Term Trading Opportunity Alerts - Newser
Is Sangamo Therapeutics Inc.’s ROE strong enough2025 Growth vs Value & Weekly Breakout Watchlists - khodrobank.com
Chart based analysis of Sangamo Therapeutics Inc. trendsBond Market & Weekly Return Optimization Alerts - Newser
Should you hold or exit Sangamo Therapeutics Inc. nowLayoff News & Risk Controlled Stock Pick Alerts - Newser
Sangamo Therapeutics Inc. stock trend outlook and recovery pathEarnings Growth Summary & Real-Time Chart Breakout Alerts - Newser
Technical analysis overview for Sangamo Therapeutics Inc. stock2025 Stock Rankings & Consistent Profit Alerts - Newser
Will Sangamo Therapeutics Inc. bounce back from current support2025 Volatility Report & Precise Swing Trade Entry Alerts - Newser
Is Sangamo Therapeutics Inc. benefiting from innovation trendsJuly 2025 Patterns & Fast Exit and Entry Trade Guides - khodrobank.com
Is Sangamo Therapeutics Inc. a cyclical or defensive stockPortfolio Profit Report & Community Verified Watchlist Alerts - khodrobank.com
Evaluating Sangamo Therapeutics Inc. with trendline analysisMarket Risk Summary & Proven Capital Preservation Methods - Newser
Reversal indicators forming on Sangamo Therapeutics Inc. stockJuly 2025 Trade Ideas & Stock Portfolio Risk Management - Newser
CEO Moves: Should I buy Sangamo Therapeutics Inc. stock now2025 Risk Factors & Weekly Stock Breakout Alerts - خودرو بانک
Does Sangamo Therapeutics Inc. fit your quant trading modelWeekly Trade Report & Weekly Hot Stock Watchlists - Newser
What is Sangamo Therapeutics Inc.’s valuation compared to sectorJuly 2025 Opening Moves & Real-Time Chart Pattern Alerts - khodrobank.com
Analyzing Sangamo Therapeutics Inc. with multi timeframe chartsInflation Watch & Real-Time Buy Signal Alerts - Newser
Will Sangamo Therapeutics Inc. benefit from current market trendsQuarterly Trade Report & High Accuracy Swing Entry Alerts - خودرو بانک
What are Sangamo Therapeutics Inc.’s recent SEC filings showingWeekly Stock Summary & Daily Growth Stock Tips - khodrobank.com
Is Sangamo Therapeutics Inc. benefiting from interest rate changesTrade Entry Report & Free Real-Time Market Sentiment Alerts - khodrobank.com
Measuring Sangamo Therapeutics Inc.’s beta against major indices2025 Short Interest & High Accuracy Trade Signal Alerts - Newser
Developing predictive dashboards with Sangamo Therapeutics Inc. data2025 Risk Factors & Growth-Oriented Investment Plans - Newser
Will Sangamo Therapeutics Inc. outperform the marketTrade Volume Report & Real-Time Volume Trigger Notifications - Newser
What MACD signals say about Sangamo Therapeutics Inc.July 2025 Volume & Smart Allocation Stock Reports - Newser
Is Sangamo Therapeutics Inc. building a consolidation baseTrade Risk Assessment & Free Daily Entry Point Trade Alerts - Newser
What Fibonacci levels say about Sangamo Therapeutics Inc. rebound2025 Momentum Check & Expert Verified Movement Alerts - Newser
What institutional flow reveals about Sangamo Therapeutics Inc.Portfolio Gains Report & Safe Swing Trade Setups - Newser
Sangamo Therapeutics Inc Azioni (SGMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):